Quantitation of Opiates to Low ng/mL Levels in Urine for Forensic Use Usingan Affordable, High-Resolution,Accurate-Mass Mass Spectrometer

Importance of the Topic

The accurate quantitation of opiates in human urine is critical for forensic toxicology, clinical diagnostics and regulatory compliance. Low nanogram-per-milliliter sensitivity ensures reliable detection of drug exposure, supports legal investigations and enhances public health safety.

Objectives and Study Overview

This study evaluated the performance of the Thermo Scientific Q Exactive Focus hybrid quadrupole-Orbitrap mass spectrometer coupled with HPLC for quantitative analysis of six opiates (morphine, codeine, hydromorphone, hydrocodone, oxymorphone and oxycodone) in human urine. The goal was to establish limits of quantitation (LOQs) in the low ng/mL range suitable for forensic use.

Methodology

Samples underwent enzymatic hydrolysis with β-glucuronidase, followed by centrifugation and dilution. Calibrators and quality controls were prepared in synthetic urine over 1–5000 ng/mL. Data acquisition used parallel reaction monitoring (PRM) with a 3.0 m/z isolation width and 35,000 resolution. Two product ions per analyte were monitored for quantification and confirmation. Matrix effects were assessed by comparing internal standard response in 58 donor urine samples against water.

Used Instrumentation

• Liquid Chromatography: Thermo Scientific Dionex UltiMate 3000 RSLC with OAS autosampler; Accucore PFP column (50 × 2.1 mm, 2.6 µm); mobile phase A: 10 mM ammonium acetate/0.1% formic acid in water; B: methanol.
• Mass Spectrometry: Thermo Scientific Q Exactive Focus MS with Ion Max source and HESI-II probe; data processed in TraceFinder software.

Main Results and Discussion

LOQs were established at 2.5 ng/mL for codeine, oxycodone and oxymorphone, and 5 ng/mL for morphine, hydrocodone and hydromorphone. Inter- and intra-assay precision (%RSD) remained below 8% across all concentration levels, with biases within ±7%. Matrix effects were minimal: internal standard recoveries ranged from 69% to 81%. Representative calibration curves exhibited linearity over three orders of magnitude, and PRM chromatograms confirmed robust ion ratio consistency at LOQ.

Benefits and Practical Applications

This method provides:

• High sensitivity and specificity for forensic and clinical urine analysis.
• Rapid throughput with a 5.3-minute run time per sample.
• Reliable confirmation via full MS/MS spectra and multiple confirming ions.
• Cost-effective dual capability for broad screening and targeted quantitation.

Future Trends and Application Possibilities

Advancements may include broader drug panels incorporating novel psychoactive substances, automation of sample preparation, and integration with forensic data management systems. Improved software algorithms for real-time data review and enhanced spectral libraries could further streamline workflows.

Conclusion

The Q Exactive Focus MS method delivers accurate, precise quantitation of six opiates at low ng/mL levels in urine. Its combination of high resolution, mass accuracy and rapid throughput makes it an ideal platform for forensic toxicology laboratories seeking both screening and quantitative confirmation capabilities.

References

• Kozak M.; Van Natta K. Thermo Fisher Scientific Application Note 616: Forensic Screening for Drugs in Urine Using High-Resolution MS/MS Spectra and Simplified High-Performance Screening Software, 2014.